{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:44:51Z","timestamp":1793857491351,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["ZKX24029"],"award-info":[{"award-number":["ZKX24029"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-026-00634-y","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:09:14Z","timestamp":1773367754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inverse association between hydroxychloroquine use and depressive symptoms in systemic lupus erythematosus: a single-center cross-sectional study"],"prefix":"10.1186","volume":"10","author":[{"given":"Xiaoqin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinglei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"10441","key":"634_CR1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet. 2024;403(10441):2326\u201338.","journal-title":"Lancet"},{"issue":"4","key":"634_CR2","doi-asserted-by":"publisher","first-page":"102780","DOI":"10.1016\/j.autrev.2021.102780","volume":"20","author":"I Carri\u00f3n-Barber\u00e0","year":"2021","unstructured":"Carri\u00f3n-Barber\u00e0 I, Salman-Monte TC, V\u00edlchez-Oya F, Monfort J. Neuropsychiatric involvement in systemic lupus erythematosus: A review. Autoimmun Rev. 2021;20(4):102780.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"634_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semarthrit.2019.06.017","volume":"50","author":"AT Moustafa","year":"2020","unstructured":"Moustafa AT, Moazzami M, Engel L, Bangert E, Hassanein M, Marzouk S, Kravtsenyuk M, Fung W, Eder L, Su J, et al. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020;50(1):84\u201394.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"634_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12888-022-03739-z","volume":"22","author":"N Narupan","year":"2022","unstructured":"Narupan N, Seeherunwong A, Pumpuang W. Prevalence and biopsychosocial factors associated with depressive symptoms among patients living with systemic lupus erythematosus in clinical settings in urban Thailand. BMC Psychiatry. 2022;22(1):103.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"634_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/acr.24398","volume":"73","author":"B Dietz","year":"2021","unstructured":"Dietz B, Katz P, Dall\u2019Era M, Murphy LB, Lanata C, Trupin L, Criswell LA, Yazdany J. Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results From a Prospective Longitudinal Cohort. Arthritis Care Res (Hoboken). 2021;73(1):48\u201354.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"634_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/09612033231173510","volume":"32","author":"P Le\u00f3n-Su\u00e1rez","year":"2023","unstructured":"Le\u00f3n-Su\u00e1rez P, R\u00faa-Figueroa I, Gonz\u00e1lez Mart\u00edn J, Rodr\u00edguez-Sosa T, Erausquin C, Almeida Santiago CDP, et al. Depression and anxiety in systemic lupus erythematosus: A case-control study on prevalence and associated factors in a single-center cohort. Lupus. 2023;32(7):827\u201332.","journal-title":"Lupus"},{"key":"634_CR7","doi-asserted-by":"publisher","first-page":"859840","DOI":"10.3389\/fmed.2022.859840","volume":"9","author":"E Elefante","year":"2022","unstructured":"Elefante E, Tani C, Stagnaro C, Signorini V, Lenzi B, Zucchi D, Trentin F, Carli L, Ferro F, Mosca M. Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life. Front Med (Lausanne). 2022;9:859840.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"634_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1573397114666180926101513","volume":"15","author":"A Kwan","year":"2019","unstructured":"Kwan A, Katz P, Touma Z. The Assessment of Anxiety and Depression and its Associated Factors in SLE. Curr Rheumatol Rev. 2019;15(2):90\u20138.","journal-title":"Curr Rheumatol Rev"},{"issue":"11","key":"634_CR9","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/rheumatology\/keaa098","volume":"59","author":"D Eldeiry","year":"2020","unstructured":"Eldeiry D, Zandy M, Tayer-Shifman OE, Kwan A, Marzouk S, Su J, Bingham K, Touma Z. Association between depression and anxiety with skin and musculoskeletal clinical phenotypes in systemic lupus erythematosus. Rheumatology (Oxford). 2020;59(11):3211\u201320.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"634_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/rheumatology\/keae070","volume":"64","author":"L Yang","year":"2025","unstructured":"Yang L, Gu B, Wang X, Ren Q, Shen M, Su D. Association of disease activity with depression and anxiety in systemic lupus erythematosus: a comparison of SLEDAI-2K and SLE-DAS. Rheumatology (Oxford). 2025;64(2):632\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"634_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13075-021-02466-2","volume":"23","author":"Y Miyawaki","year":"2021","unstructured":"Miyawaki Y, Shimizu S, Ogawa Y, Sada KE, Katayama Y, Asano Y, Hayashi K, Yamamura Y, Hiramatsu-Asano S, Ohashi K, et al. Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study. Arthritis Res Ther. 2021;23(1):79.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"634_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15\u201329.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"634_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","volume":"57","author":"C Gordon","year":"2018","unstructured":"Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D\u2019Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford). 2018;57(1):e1\u201345.","journal-title":"Rheumatology (Oxford)"},{"issue":"14","key":"634_CR14","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1177\/09612033221129774","volume":"31","author":"T Cai","year":"2022","unstructured":"Cai T, Zhao J, Yang Y, Jiang Y, Zhang JA. Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: A systematic review and meta-analysis of cohort studies. Lupus. 2022;31(14):1714\u201325.","journal-title":"Lupus"},{"key":"634_CR15","doi-asserted-by":"publisher","first-page":"1759720x2110730","DOI":"10.1177\/1759720X211073001","volume":"14","author":"A Dima","year":"2022","unstructured":"Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther Adv Musculoskelet Dis. 2022;14:1759720x211073001.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"12","key":"634_CR16","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1093\/rheumatology\/kex357","volume":"56","author":"CY Hsu","year":"2017","unstructured":"Hsu CY, Lin YS, Su YJ, Lin HF, Lin MS, Syu YJ, Cheng TT, Yu SF, Chen JF, Chen TH. Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study. Rheumatology (Oxford). 2017;56(12):2212\u201321.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"634_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3949\/ccjm.85a.17034","volume":"85","author":"EA Shippey","year":"2018","unstructured":"Shippey EA, Wagler VD, Collamer AN. Hydroxychloroquine: An old drug with new relevance. Cleve Clin J Med. 2018;85(6):459\u201367.","journal-title":"Cleve Clin J Med"},{"key":"634_CR18","doi-asserted-by":"publisher","first-page":"105582","DOI":"10.1016\/j.phrs.2021.105582","volume":"168","author":"PMP Ferreira","year":"2021","unstructured":"Ferreira PMP, Sousa RWR, Ferreira JRO, Milit\u00e3o GCG, Bezerra DP. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res. 2021;168:105582.","journal-title":"Pharmacol Res"},{"issue":"7","key":"634_CR19","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1093\/rheumatology\/keaa771","volume":"60","author":"JCE Lane","year":"2021","unstructured":"Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MTF, Alghoul H, Alser O, Alshammari TM, Areia C, Biedermann P, et al. Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). 2021;60(7):3222\u201334.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"634_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/10600280221113572","volume":"57","author":"F Talarico","year":"2023","unstructured":"Talarico F, Chakravarty S, Liu YS, Greenshaw AJ, Passos IC, Cao B. Systematic Review of Psychiatric Adverse Effects Induced by Chloroquine and Hydroxychloroquine: Case Reports and Population Studies. Ann Pharmacother. 2023;57(4):463\u201379.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"634_CR21","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"634_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"634_CR23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","volume":"76","author":"R van Vollenhoven","year":"2017","unstructured":"van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Bal\u00e1\u017eov\u00e1 P, Bonfa E, Bootsma H, et al. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis. 2017;76(3):554\u201361.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"634_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"634_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"634_CR26","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/acr.23109","volume":"69","author":"A Polachek","year":"2017","unstructured":"Polachek A, Gladman DD, Su J, Urowitz MB. Defining Low Disease Activity in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017;69(7):997\u20131003.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"634_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11325-021-02405-0","volume":"26","author":"R Yin","year":"2022","unstructured":"Yin R, Li L, Xu L, Sui W, Niu M, Xu R, Srirat C. Association between depression and sleep quality in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Sleep Breath. 2022;26(1):429\u201341.","journal-title":"Sleep Breath"},{"issue":"2","key":"634_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/0961203313518623","volume":"23","author":"L Palagini","year":"2014","unstructured":"Palagini L, Tani C, Mauri M, Carli L, Vagnani S, Bombardieri S, Gemignani A, Mosca M. Sleep disorders and systemic lupus erythematosus. Lupus. 2014;23(2):115\u201323.","journal-title":"Lupus"},{"issue":"6","key":"634_CR29","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/bjd.17257","volume":"180","author":"M Tarazi","year":"2019","unstructured":"Tarazi M, Gaffney RG, Pearson D, Kushner CJ, Werth VP. Fatigue in systemic lupus erythematosus and other autoimmune skin diseases. Br J Dermatol. 2019;180(6):1468\u201372.","journal-title":"Br J Dermatol"},{"issue":"11","key":"634_CR30","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3899\/jrheum.180831","volume":"46","author":"A Barbacki","year":"2019","unstructured":"Barbacki A, Petri M, Avi\u00f1a-Zubieta A, Alarc\u00f3n GS, Bernatsky S. Fatigue Measurements in Systemic Lupus Erythematosus. J Rheumatol. 2019;46(11):1470\u20137.","journal-title":"J Rheumatol"},{"key":"634_CR31","doi-asserted-by":"crossref","unstructured":"Kawka L, Schlencker A, Mertz P, Martin T, Arnaud L. Fatigue in systemic lupus erythematosus: an update on its impact, determinants and therapeutic management. J Clin Med. 2021;10(17).","DOI":"10.3390\/jcm10173996"},{"issue":"2","key":"634_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107(2):234\u201356.","journal-title":"Neuron"},{"issue":"10371","key":"634_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","volume":"401","author":"S Marwaha","year":"2023","unstructured":"Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R. Novel and emerging treatments for major depression. Lancet. 2023;401(10371):141\u201353.","journal-title":"Lancet"},{"issue":"12","key":"634_CR34","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41584-023-01037-w","volume":"19","author":"J Brock","year":"2023","unstructured":"Brock J, Basu N, Schlachetzki JCM, Schett G, McInnes IB, Cavanagh J. Immune mechanisms of depression in rheumatoid arthritis. Nat Rev Rheumatol. 2023;19(12):790\u2013804.","journal-title":"Nat Rev Rheumatol"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00634-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:44:10Z","timestamp":1776732250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00634-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00634-y","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Nanjing First Hospital (Ethic approval number: KY20240603-KS-02). Prior to participation, written informed consent was obtained from all individuals involved in the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}